Bcl-x is required for proper development of the mouse substantia nigra

被引:130
作者
Savitt, JM
Jang, SS
Mu, WT
Dawson, VL
Dawson, TM
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Baltimore, MD 21205 USA
关键词
Parkinson; Bcl-x; catecholamine; substantia nigra; dopamine; tyrosine hydroxylase;
D O I
10.1523/JNEUROSCI.0760-05.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent findings have uncovered a role for the Bcl-x gene in the survival of dopaminergic neurons. The exact nature of this role has been difficult to examine because of the embryonic lethality of Bcl-x gene disruption in mouse models. Here we report the generation of catecholaminergic cell-specific conditional Bcl-x gene knock-out mice using Cre-1ox recombination technology. First we produced transgenic mice that express Cre recombinase from an exogenous rat tyrosine hydroxylase promoter (TH-Cre mice). These mice were crossed to Z/AP and Z/EG reporter mouse strains to verify catecholaminergic (TH-positive) cell-specific Cre expression. The TH-Cre mice then were mated to mice possessing the Bcl-x gene flanked by loxP sites, thereby producing offspring with Bcl-x deletion limited to catecholaminergic cells. The resulting mice are viable but have one-third fewer catecholaminergic neurons than do control animals. They demonstrate a deficiency in striatal dopamine and also tend to be smaller and have decreased brain mass when compared with controls. Surprisingly, surviving neurons were found that lacked Bcl-x immunoreactivity, thereby demonstrating that this gene is dispensable for the ongoing survival of a subpopulation of catecholaminergic cells.
引用
收藏
页码:6721 / 6728
页数:8
相关论文
共 51 条
[1]   Bcl-xL protects adult septal cholinergic neurons from axotomized cell death [J].
Blömer, U ;
Kafri, T ;
Randolph-Moore, L ;
Verma, IM ;
Gage, FH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2603-2608
[2]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[3]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[4]   Molecular pathways of neurodegeneration in Parkinson's disease [J].
Dawson, TM ;
Dawson, VL .
SCIENCE, 2003, 302 (5646) :819-822
[5]   FUNCTION AND EXPRESSION OF THE BCL-X GENE IN THE DEVELOPING AND ADULT NERVOUS-SYSTEM [J].
FRANKOWSKI, H ;
MISSOTTEN, M ;
FERNANDEZ, PA ;
MARTINOU, I ;
MICHEL, P ;
SADOUL, R ;
MARTINOU, JC .
NEUROREPORT, 1995, 6 (14) :1917-1921
[6]   Transgenic mice engineered to target Cre/LoxP-mediated DNA recombination into catecholaminergic neurons [J].
Gelman, DM ;
Noaín, D ;
Avale, ME ;
Otero, V ;
Low, MJ ;
Rubinstein, M .
GENESIS, 2003, 36 (04) :196-202
[7]   BCL-X IS EXPRESSED IN EMBRYONIC AND POSTNATAL NEURAL TISSUES AND FUNCTIONS TO PREVENT NEURONAL CELL-DEATH [J].
GONZALEZGARCIA, M ;
GARCIA, I ;
DING, LY ;
OSHEA, S ;
BOISE, LH ;
THOMPSON, CB ;
NUNEZ, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4304-4308
[8]   NEUROPATHOLOGY OF IMMUNOHISTOCHEMICALLY IDENTIFIED BRAIN-STEM NEURONS IN PARKINSONS-DISEASE [J].
HALLIDAY, GM ;
LI, YW ;
BLUMBERGS, PC ;
JOH, TH ;
COTTON, RGH ;
HOWE, PRC ;
BLESSING, WW ;
GEFFEN, LB .
ANNALS OF NEUROLOGY, 1990, 27 (04) :373-385
[9]   Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease [J].
Hartmann, A ;
Mouatt-Prigent, A ;
Vila, M ;
Abbas, N ;
Perier, C ;
Faucheux, BA ;
Vyas, S ;
Hirsch, EC .
NEUROBIOLOGY OF DISEASE, 2002, 10 (01) :28-32
[10]   bcl-XL is critical for dendritic cell survival in vivo [J].
Hon, H ;
Rucker, EB ;
Hennighausen, L ;
Jacob, J .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4425-4432